SEARCH

SEARCH BY CITATION

References

  • Adams, R., McKie, V., Nichols, F., Carl, E., Zhang, D.-L., McKie, K., Figueroa, R., Litaker, M., Thompson, W. & Hess, D. (1992) The use of transcranial ultrasonography to predict stroke in sickle cell disease. New England Journal of Medicine, 326, 605610.
  • Adams, R.J., Kutlar, A., McKie, V., Carl, E., Nichols, F.T., Liu, J.C., McKie, K. & Clary, A. (1994) Alpha thalassemia and stroke risk in sickle cell anemia. American Journal of Hematology, 45, 279282.
  • Adams, R.J., McKie, V.C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F.T., Bonds, D.R. & Brambilla, D. (1998) Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. New England Journal of Medicine, 339, 511.
  • Adedeji, M.O., Onuora, V.C. & Ukoli, F.A. (1988) Haematological parameters associated with priapism in Nigerian patients with homozygous sickle cell disease. Journal of Tropical Medicine and Hygiene, 91, 157159.
  • Adekile, A.D. & Haider, M.Z. (1996) Morbidity, βs haplotype and α-globin gene patterns among sickle cell anemia patients in Kuwait. Acta Haematologica, 96, 150154.
  • Adekile, A.D., Tuli, M., Haider, M.Z., Al-Zaabi, K., Mohannadi, S. & Owunwanne, A. (1996) Influence of α-thalassemia trait on spleen function in sickle cell anemia patients with high HbF. American Journal of Hematology, 53, 15.
  • Adekile, A.D., Kutlar, F., Haider, M.Z. & Kutlar, A. (2001) Frequency of the 677 C[RIGHTWARDS ARROW]T mutation of the methylenetetrahydrofolate reductase gene among Kuwaiti sickle cell disease patients. American Journal of Hematology, 66, 263266.
  • Adekile, A.D., Yacoub, F., Gupta, R., Sinan, T., Haider, M.Z., Habeeb, Y., Al Bloushi, M. & Moosa, A. (2002) Silent brain infarcts are rare in Kuwaiti children with sickle cell disease and high Hb F. American Journal of Hematology, 70, 228231.
  • Alexander, N., Higgs, D., Dover, G. & Serjeant, G.R. (2004) Are there clinical phenotypes of homozygous sickle cell disease? British Journal of Haematology, 126, 606611.
  • Ameshima, S., Golpon, H., Cool, C.D., Chan, D., Vandivier, R.W., Gardai, S.J., Wick, M., Nemenoff, R.A., Geraci, M.W. & Voelkel, N.F. (2003) Peroxisome proliferator-activated receptor gamma (PPARgamma) expression is decreased in pulmonary hypertension and affects endothelial cell growth. Circulation Research, 92, 11621169.
  • Andrade, F.L., Annichino-Bizzacchi, J.M., Saad, S.T.O., Costa, F.F. & Arruda, V.R. (1998) Prothrombin mutant, factor V Leiden, and thermolabile variant of methylenetetrahydrofolate reductase among patients with sickle cell disease in Brazil. American Journal of Hematology, 59, 4650.
  • Ashley-Koch, A., DeCastro, L., Lennon-Graham, F., Jonassaint, J., Jackson, T.L., Price, J., Galloway, J., Ataga, K., Orringer, E.P., Vance, J.M. & Telen, M.J. (2004) Genetic polymorphisms associated with the risk for pulmonary hypertension and proteinuria in sickle cell disease. Blood, 104, 464a.
  • Bailey, K., Morris, J.S., Thomas, P. & Serjeant, G.R. (1992) Fetal haemoglobin and early manifestations of homozygous sickle cell disease. Archives of Diseases in Childhood, 67, 517520.
  • Bakanay, S.M., Dainer, E., Clair, B., Adekile, A., Daitch, L., Wells, L., Holley, L., Smith, D. & Kutlar, A. (2005) Mortality in sickle cell patients on hydroxyurea therapy. Blood, 105, 545547.
  • Baliga, B.S., Pace, B.S., Chen, H.H., Shah, A.K. & Yang, Y.M. (2000) Mechanism for fetal hemoglobin induction by hydroxyurea in sickle cell erythroid progenitors. American Journal of Hematology, 65, 227233.
  • Balkaran, B., Char, G., Morris, J.S., Thomas, P.W., Serjeant, B.E. & Serjeant, G.R. (1992) Stroke in a cohort of patients with homozygous sickle cell disease. Journal of Pediatrics, 120, 360366.
  • Ballas, S.K., Talacki, C.A., Rao, V.N. & Steiner, R.M. (1989) The prevalence of avascular necrosis in sickle cell anemia: correlation with alpha-thalassemia. Hemoglobin, 13, 649655.
  • Ballas, S.K., Talacki, C.A., Adachi, K., Schwartz, E., Surrey, S. & Rappaport, E. (1991) The XMN I site (-158, C[RIGHTWARDS ARROW]T) 5′ to the Ggamma gene: Correlation with the Senegalese haplotype and Gγ globin expression. Hemoglobin, 15, 393405.
  • Billett, H.H., Nagel, R.L. & Fabry, M.E. (1995) Paradoxical increase of painful crises in sickle cell patients with α-thalassemia. Blood, 86, 4382.
  • Blobel, G.A. & Weiss, M.J. (2001) Nuclear factors that regulate erythropoiesis. In: Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management (ed. by M. H.Steinberg, B. G.Forget, D. R.Higgs & R. L.Nagel), pp. 7294. Cambridge University Press, Cambridge.
  • Braden, D.S., Covitz, W. & Milner, P.F. (1996) Cardiovascular function during rest and exercise in patients with sickle-cellanemia and coexisting alpha thalassemia-2. American Journal of Hematology, 52, 96102.
  • Bray, G.L., Muenz, L., Makris, N. & Lessin, L.S. (1994) Assessing clinical severity in children with sickle cell disease. Preliminary results from a cooperative study. American Journal of Pediatric Hematology and Oncology, 16, 5054.
  • Castro, O., Brambilla, D.J., Thorington, B., Reindorf, C.A., Scott, R.B., Gillette, P., Vera, J.C., Levy, P.S. & Coop Study of Sickle Cell Disease (1994) The acute chest syndrome in sickle cell disease: Incidence and risk factors. Blood, 84, 643649.
  • Castro, V., Alberto, F.L., Costa, R.N., Lepikson-Neto, J., Gualandro, S.F., Figueiredo, M.S., Annichino-Bizzacchi, J.M., Saad, S.T. & Costa, F.F. (2004) Polymorphism of the human platelet antigen-5 system is a risk factor for occlusive vascular complications in patients with sickle cell anemia. Vox Sanguinis, 87, 118123.
  • Chang, Y.C., Smith, K.D., Moore, R.D., Serjeant, G.R. & Dover, G.J. (1995) An analysis of fetal hemoglobin variation in sickle cell disease: The relative contributions of the X-linked factor, β-globin haplotypes, α-globin gene number, gender, and age. Blood, 85, 11111117.
  • Chang, Y.P.C., Maier-Redelsperger, M., Smith, K.D., Contu, L., Ducrocq, R., De Montalembert, M., Belloy, M., Elion, J., Dover, G.J. & Girot, R. (1997) The relative importance of the x-linked FCP locus and β- globin haplotypes in determining haemoglobin F levels: A study of SS patients homozygous for βShaplotypes. British Journal of Haematology, 96, 806814.
  • Charache, S., Terrin, M.L., Moore, R.D., Dover, G.J., Barton, F.B., Eckert, S.V., McMahon, R.P., Bonds, D.R. & Multicenter Study of Hydroxyurea in Sickle Cell Anemia (1995) Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. New England Journal of Medicine, 332, 13171322.
  • Close, J., Game, L., Clark, B., Bergounioux, J., Gerovassili, A. & Thein, S.L. (2004) Genome annotation of a 1·5 Mb region of human chromosome 6q23 encompassing a quantitative trait locus for fetal hemoglobin expression in adults. BMC Genomics, 5, 33.
  • Cohen, A.R. & Porter, J.B. (2001) Transfusion and iron chelation therapy in in thalassemia and sickle cell anemia. In: Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management (ed. by M. H.Steinberg, D. R.Higgs, B. G.Forget & R. L.Nagel), pp. 9791027. Cambridge University Press, Cambridge.
  • Cokic, V.P., Smith, R.D., Beleslin-Cokic, B.B., Njoroge, J.M., Miller, J.L., Gladwin, M.T. & Schechter, A.N. (2003) Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase. Journal of Clinical Investigation, 111, 231239.
  • Condon, P.I., Marsh, R.J., Maude, G.H., Higgs, D.R., Weatherall, D.J. & Serjeant, G.R. (1983) Alpha thalassaemia and the macular vasculature in homozygous sickle cell disease. British Journal of Ophthalmology, 67, 779781.
  • De Castro, L., Rinder, H.M., Howe, J.G. & Smith, B.R. (1998) Thrombophilic genotypes do not adversely affect the course of sickle cell disease (SCD). Blood, 92, 161a.
  • De Ceulaer, K. & Serjeant, G.R. (1991) Acute splenic sequestration in Jamaican adults with homozygous sickle cell disease: a role of alpha thalassaemia. British Journal of Haematology, 77, 563564.
  • De Ceulaer, K., Higgs, D.R., Weatherall, D.J., Hayes, R.J., Serjeant, B.E. & Serjeant, G.R. (1983) Alpha-Thalassemia reduces the hemolytic rate in homozygous sickle-cell disease. New England Journal of Medicine, 309, 189190.
  • Dimovski, A.J., Öner, C., Agarwal, S., Gu, Y.-C., Gu, L.-H., Kutlar, F., Lanclos, K.D. & Huisman, T.H.J. (1991) Certain mutations observed in the 5′ sequences of the Gγ-and Aγ-globin genes of βS chromosomes are specific for chromosomes with major haplotypes. Acta Haematologica (Basel), 85, 7987.
  • Donaldson, A., Thomas, P., Serjeant, B.E. & Serjeant, G.R. (2001) Foetal haemoglobin in homozygous sickle cell disease: a study of patients with low HBF levels. Clinical and Laboratory Haematology, 23, 285289.
  • Dover, G.J. & Boyer, S.H. (1980) Quantitation of hemoglobins within individual red cells: asynchronous biosynthesis of fetal and adult hemoglobin during erythroid maturation in normal subjects. Blood, 56, 10821091.
  • Dover, G.J., Chang, V.T., Boyer, S.H., Serjeant, G.R., Antonarakis, S. & Higgs, D.R. (1987) The cellular basis for different fetal hemoglobin levels among sickle cell individuals with two, three, and four alpha-globin genes. Blood, 69, 341344.
  • Dover, G.J., Smith, K.D., Chang, Y.C., Purvis, S., Mays, A., Meyers, D.A., Sheils, C. & Serjeant, G. (1992) Fetal hemoglobin levels in sickle cell disease and normal individuals are partially controlled by an X-linked gene located at Xp22.2. Blood, 80, 816824.
  • Driscoll, M.C., Hurlet, A., Styles, L., McKie, V., Files, B., Olivieri, N., Pegelow, C., Berman, B., Drachtman, R., Patel, K. & Brambilla, D. (2003) Stroke risk in siblings with sickle cell anemia. Blood, 101, 24012404.
  • Driscoll, M.C., Devaney, J., Gordish, H., Minniti, C & Hoffman, E.P. (2004) Genetic modifiers of cerebrovascular large vessel stenosis in sickle cell anemia. Blood, 104, 461a.
  • El-Hazmi, M.A.F. (1992a) Clinical and haematological diversity of sickle cell disease in Saudi children. Journal of Tropical Pediatrics, 38, 106112.
  • El-Hazmi, M.A.F. (1992b) Heterogeneity and variation of clinical and haematological expression of haemoglobin S in Saudi Arabs. Acta Haematologica, 88, 6771.
  • El-Hazmi, M.A.F., Bahakim, H.M. & Warsy, A.S. (1992) DNA polymorphism in the beta-globin gene cluster in Saudi Arabs: Relation to severity of sickle cell anaemia. Acta Haematologica, 88, 6166.
  • Embury, S.H., Dozy, A.M., Miller, J., Davis, J.R. Jr., Kleman, K.M., Preisler, H., Vichinsky, E., Lande, W.N., Lubin, B.H., Kan, Y.W. & Mentzer, W.C. (1982) Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia. New England Journal of Medicine, 306, 270274.
  • Embury, S.H., Clark, M.R., Monroy, G.M. & Mohandas, N. (1984) Concurrent sickle cell anemia and α thalassemia. Journal of Clinical Investigation, 73, 116123.
  • Eyler, C.E., Jackson, T.L., DeCastro, L., Zennadi, R., Vance, J.M., Ashley-Koch, A. & Telen, M.J. (2004) Effects of single nucleotide polymorphisms of the α 2 adrenergic receptor and of adenylate cyclase on sickle red cell adhesion to laminin. Blood, 104, 969.
  • Fadlon, E., Vordermeier, S., Pearson, T.C., Mire-Sluis, A.R., Dumonde, D.C., Phillips, J., Fishlock, K. & Brown, K.A. (1998) Blood polymorphonuclear leukocytes from the majority of sickle cell patients in the crisis phase of the disease show enhanced adhesion to vascular endothelium and increased expression of CD64. Blood, 91, 266274.
  • Ferrari, P., Schroeder, V., Anderson, S., Kocovic, L., Vogt, B., Schiesser, D., Marti, H.P., Ganz, R., Frey, F.J. & Kohler, H.P. (2002) Association of plasminogen activator inhibitor-1 genotype with avascular osteonecrosis in steroid-treated renal allograft recipients. Transplantation, 74, 11471152.
  • Fertrin, K.Y., Melo, M.B., Assis, A.M., Saad, S.T. & Costa, F.F. (2003) UDP-glucuronosyltransferase 1 gene promoter polymorphism is associated with increased serum bilirubin levels and cholecystectomy in patients with sickle cell anemia. Clinical Genetics, 64, 160162.
  • Forrester, W.C., Takegawa, S., Papayannopoulou, T., Stamatoyannopoulos, G. & Groudine, M. (1987) Evidence for a locus activation region: the formation of developmentally stable hypersensitive sites in globin-expressing hybrids. Nucleic Acids Research, 15, 1015910177.
  • Fox, P.D., Dunn, D.T., Morris, J.S. & Serjeant, G.R. (1990) Risk factors for proliferative sickle retinopathy. British Journal of Ophthalmology, 74, 172176.
  • Fox, P.D., Higgs, D.R. & Serjeant, G.R. (1993) Influence of α thalassaemia on the retinopathy of homozygous sickle cell disease. British Journal of Ophthalmology, 77, 8990.
  • Gardner, C., Robas, N., Cawkill, D. & Fidock, M. (2000) Cloning and characterization of the human and mouse PDE7B, a novel cAMP-specific cyclic nucleotide phosphodiesterase. Biochemical and Biophysical Research Communications, 272, 186192.
  • Garner, C., Mitchell, J., Hatzis, T., Reittie, J., Farrall, M. & Thein, S.L. (1998) Haplotype mapping of a major quantitative-trait locus for fetal hemoglobin production, on chromosome 6q23. American Journal of Human Genetics, 62, 14681474.
  • Garner, C.P., Tatu, T., Best, S., Creary, L. & Thein, S.L. (2002) Evidence of genetic interaction between the beta-globin complex and chromosome 8q in the expression of fetal hemoglobin. American Journal of Human Genetics, 70, 793799.
  • Garner, C., Silver, N., Best, S., Menzel, S., Martin, C., Spector, T.D. & Thein, S.L. (2004) A quantitative trait locus on chromosome 8q influences the switch from fetal to adult hemoglobin. Blood, 104, 21842186.
  • Gilman, J.G. & Huisman, T.H.J. (1985) DNA sequence variation associated with elevated fetal Gg globin production. Blood, 66, 783787.
  • Gladwin, M.T., Sachdev, V., Jison, M.L., Shizukuda, Y., Plehn, J.F., Minter, K., Brown, B., Coles, W.A., Nichols, J.S., Ernst, I., Hunter, L.A., Blackwelder, W.C., Schechter, A.N., Rodgers, G.P., Castro, O. & Ognibene, F.P. (2004) Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. New England Journal of Medicine, 350, 886895.
  • Grosveld, F., Antoniou, M., Berry, M., De Boer, E., Dillon, N., Ellis, J., Fraser, P., Hurst, J., Imam, A., Meijer, D., Philipsen, S., Pruzina, S., Strouboulis, J. & Whyatt, D. (1993) Regulation of human globin gene switching. Cold Spring Harbor Symposium on Quantitative Biology, 58, 713.
  • Guasch, A., Zayas, C.F., Eckman, J.R., Muralidharan, K., Zhang, W. & Elsas, L.J. (1999) Evidence that microdeletions in the α globin gene protect against the development of sickle cell glomerulopathy in humans. Journal of the American Society of Nephrology, 10, 10141019.
  • de Haan, G., Bystrykh, L.V., Weersing, E., Dontje, B., Geiger, H., Ivanova, N., Lemischka, I.R., Vellenga, E. & Van Zant, G. (2002) A genetic and genomic analysis identifies a cluster of genes associated with hematopoietic cell turnover. Blood, 100, 20562062.
  • Haider, M.Z., Ashebu, S., Aduh, P. & Adekile, A.D. (1998) Influence of α-thalassemia on cholelithiasis in SS patients with elevated Hb F. Acta Haematologica, 100, 147150.
  • Hargrave, D.R., Wade, A., Evans, J.P., Hewes, D.K. & Kirkham, F.J. (2003) Nocturnal oxygen saturation and painful sickle cell crises in children. Blood, 101, 846848.
  • Hattori, Y., Kutlar, F., Kutlar, A., McKie, V.C. & Huisman, T.H. (1986) Haplotypes of beta S chromosomes among patients with sickle cell anemia from Georgia. Hemoglobin, 10, 623642.
  • Haverfield, E.V., McKenzie, C.A., Forrester, T., Bouzekri, N., Harding, R., Serjeant, G., Walker, T., Peto, T.E., Ward, R. & Weatherall, D.J. (2004) UGT1A1 variation and gallstone formation in sickle cell disease. Blood, 105, 968972.
  • Hawker, H., Neilson, H., Hayes, R.J. & Serjeant, G.R. (1982) Haematological factors associated with avascular necrosis of the femoral head in homozygous sickle cell disease. British Journal of Haematology, 50, 2934.
  • Hayes, R.J., Condon, P.I. & Serjeant, G.R. (1981) Haematological factors associated with proliferative retinopathy in homozygous sickle cell disease. British Journal of Ophthalmology, 65, 2935.
  • Hebbel, R.P. (1997) Adhesive interactions of sickle erythrocytes with endothelium. Journal of Clinical Investigation, 99, 25612564.
  • Hedo, C.C., Okpala, I.E. & Aken'ova, Y.A. (1993) Foetal haemoglobin levels in Nigerians with sickle cell anaemia. A revisitation. Tropical and Geographic Medicine, 45, 162164.
  • Heeney, M.M., Howard, T.A., Zimmerman, S.A. & Ware, R.E. (2003) UGT1A promoter polymorphisms influence bilirubin response to hydroxyurea therapy in sickle cell anemia. Journal of Laboratory and Clinical Medicine, 141, 279282.
  • Higgs, D.R., Aldridge, B.E., Lamb, J., Clegg, J.B., Weatherall, D.J., Hayes, R.J., Grandison, Y., Lowrie, Y., Mason, K.P., Serjeant, B.E. & Serjeant, G.R. (1982) The interaction of alpha-thalassemia and homozygous sickle-cell disease. New England Journal of Medicine, 306, 14411446.
  • Hoppe, C., Cheng, S., Grow, M., Silbergleit, A., Klitz, W., Trachtenberg, E., Erlich, H., Vichinsky, E. & Styles, L. (2001) A novel multilocus genotyping assay to identify genetic predictors of stroke in sickle cell anaemia. British Journal of Haematology, 114, 718720.
  • Hoppe, C., Klitz, W., Noble, J., Vigil, L., Vichinsky, E. & Styles, L. (2002) Distinct HLA associations by stroke subtype in children with sickle cell anemia. Blood, 101, 28652869.
  • Hoppe, C., Klitz, W., Cheng, S., Apple, R., Steiner, L., Robles, L., Girard, T., Vichinsky, E. & Styles, L. (2004) Gene interactions and stroke risk in children with sickle cell anemia. Blood, 103, 23912396.
  • Hsu, L.L., Miller, S.T., Wright, E., Kutlar, A., McKie, V., Wang, W., Pegelow, C.H., Driscoll, C., Hurlet, A., Woods, G., Elsas, L., Embury, S. & Adams, R.J. (2003) Alpha Thalassemia is associated with decreased risk of abnormal transcranial Doppler ultrasonography in children with sickle cell anemia. Journal of Pediatric Hematology and Oncology, 25, 622628.
  • Ikuta, T., Ausenda, S. & Cappellini, M.D. (2001) Mechanism for fetal globin gene expression: Role of the soluble guanylate cyclase-cGMP-dependent protein kinase pathway. Proceedings of the National Academy of Sciences of the United States of America, 98, 18471852.
  • Inoue, T.K., Ikezaki, K., Sasazuki, T., Matsushima, T. & Fukui, M. (1997) Analysis of class II genes of human leukocyte antigen in patients with moyamoya disease. Clinical Neurology and Neurosurgery, 99 (Suppl 2), S234S237.
  • Inoue, A., Kuroyanagi, Y., Terui, K., Moi, P. & Ikuta, T. (2004) Negative regulation of gamma-globin gene expression by cyclic AMP-dependent pathway in erythroid cells. Experimental Hematology, 32, 244253.
  • Jones, A., Granger, S., Brambilla, D., Gallagher, D., Vichinsky, E., Woods, G., Berman, B., Roach, S., Nichols, F. & Adams, R.J. (2005) Can peak systolic velocities be used for prediction of stroke in sickle cell anemia? Pediatric Radiology, 35, 6672.
  • Kahn, M.J., Scher, C., Rozans, M., Michaels, R.K., Leissinger, C. & Krause, J. (1997) Factor V Leiden is not responsible for stroke in patients with sickling disorders and is uncommon in African Americans with sickle cell disease. American Journal of Hematology, 54, 1215.
  • Kaul, D.K. & Hebbel, R.P. (2000) Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice [see comments]. Journal of Clinical Investigation, 106, 411420.
  • Keclard, L., Ollendorf, V., Berchel, C., Loret, H. & Merault, G. (1996) beta S haplotypes, alpha-globin gene status, and hematological data of sickle cell disease patients in Guadeloupe (F.W.I.). Hemoglobin, 20, 6374.
  • Keclard, L., Romana, M., Lavocat, E., Saint-Martin, C., Berchel, C. & Merault, G. (1997) Sickle cell disorder, beta-globin gene cluster haplotypes and alpha-thalassemia in neonates and adults from Guadeloupe. American Journal of Hematology, 55, 2427.
  • Kinney, T.R., Sleeper, L.A., Wang, W.C., Zimmerman, R.A., Pegelow, C.H., Ohene-Frempong, K., Wethers, D.L., Bello, J.A., Vichinsky, E.P., Moser, F.G., Gallagher, D.M., DeBaun, M.R., Platt, O.S. & Miller, S.T. (1999) Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. Pediatrics, 103, 640645.
  • Koshy, M., Entsuah, R., Koranda, A., Kraus, A.P., Johnson, R., Bellvue, R., Flournoy-Gill, Z. & Levy, P. (1989) Leg ulcers in patients with sickle cell disease [see comments]. Blood, 74, 14031408.
  • Kulozik, A.E., Wainscoat, J.S., Serjeant, G.R., Kar, B.C., Al-Awamy, B., Essan, G.J.F., Falusi, A.G., Haque, S.K., Hilali, A.M., Kate, S., Ranasinghe, W.A.E.P. & Weatherall, D.J. (1986) Geographical survey of the βs-globin gene haplotypes: Evidence for an independent Asian origin of the sickle-cell mutation. American Journal of Human Genetics, 39, 239244.
  • Kulozik, A.E., Kar, B.C., Satapathy, R.K., Serjeant, B.E., Serjeant, G.R. & Weatherall, D.J. (1987) Fetal hemoglobin levels and βS globin haplotypes in an Indian population with sickle cell disease. Blood, 69, 17421746.
  • Kutlar, F., Tural, C., Park, D., Markowitz, R.B., Woods, K.F. & Kutlar, A. (1998) MTHFR (5, 10-methlylenetetrathydrofolate reductase) 677 C->T mutation as a candidate risk factor for avascular necrosis (AVN) in patients with sickle cell disease. Blood, 92, 695a.
  • Labie, D., Pagnier, J., Lapoumeroulie, C., Rouabhi, F., Dunda-Belkhodja, O., Chardin, P., Beldjord, C., Wajcman, H., Fabry, M.E. & Nagel, R.L. (1985) Common haplotype dependency of high G γ-globin gene expression and high HbF levels in βthalassemia and sickle cell anemia patients. Proceedings of the National Academy of Sciences of the United States of America, 82, 21112114.
  • Labie, D., Srinivas, R., Dunda, O., Dode, C., Lapoumeroulie, C., Devi, V., Devi, S., Ramasami, K., Elion, J., Ducrocq, R., Krishnamoorthy, R. & Nagel, R.L. (1989) Haplotypes in tribal Indians bearing the sickle gene: evidence for the unicentric origin of the beta S mutation and the unicentric origin of the tribal populations of India. Human Biology, 61, 479491.
  • Lard, L.R., Mul, F.P.J., De Haas, M., Roos, D. & Duits, A.J. (1999) Neutrophil activation in sickle cell disease. Journal of Leukocyte Biology, 66, 411415.
  • Liesner, R., Mackie, I., Cookson, J., McDonald, S., Chitolie, A., Donohoe, S., Evans, J., Hann, I. & Machin, S. (1998) Prothrombotic changes in children with sickle cell disease: relationships to cerebrovascular disease and transfusion. British Journal of Haematology, 103, 10371044.
  • Liu, X. & Barker, D.F. (1999) Evidence for effective suppression of recombination in the chromosome 17q21 segment spanning RNU2-BRCA1. American Journal of Human Genetics, 64, 14271439.
  • Lu, Z.H. & Steinberg, M.H. (1996) Fetal hemoglobin in sickle cell anemia: Relation to regulatory sequences cis to the β-globin gene. Blood, 87, 16041611.
  • Machado, R.D., Pauciulo, M.W., Thomson, J.R., Lane, K.B., Morgan, N.V., Wheeler, L., Phillips, J.A. III., Newman, J., Williams, D., Galie, N., Manes, A., McNeil, K., Yacoub, M., Mikhail, G., Rogers, P., Corris, P., Humbert, M., Donnai, D., Martensson, G., Tranebjaerg, L., Loyd, J.E., Trembath, R.C. & Nichols, W.C. (2001) BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. American Journal of Human Genetics, 68, 92102.
  • Martinez, G., Muniz, A., Svarch, E., Espinosa, E. & Nagel, R.L. (1996) Age dependence of the gene frequency of α-thalassemia in sickle cell anemia in Cuba. Blood, 88, 18981899.
  • Mears, J.G., Lachman, H.M., Labie, D. & Nagel, R.L. (1983) Alpha thalassemia is related to prolonged survival in sickle cell anemia. Blood, 62, 286.
  • Miller, B.A., Salameh, M., Ahmed, M., Olivieri, N., Huisman, T.H., Orkin, S.H. & Nathan, D.G. (1987) Analysis of high fetal hemoglobin production in sickle cell anemia patients from the Eastern Province of Saudi Arabia. Progress In Clinical and Biological Research, 251, 415426.
  • Miller, S.T., Rieder, R.F., Rao, S.P. & Brown, A.K. (1988) Cerebrovascular accidents in children with sickle-cell disease and alpha-thalassemia. Journal of Pediatrics, 118, 847849.
  • Miller, S.T., Sleeper, L.A., Pegelow, C.H., Enos, L.E., Wang, W.C., Weiner, S.J., Wethers, D.L., Smith, J. & Kinney, T.R. (2000) Prediction of adverse outcomes in children with sickle cell disease. New England Journal of Medicine, 342, 8389.
  • Milner, P.F., Kraus, A.P., Sebes, J.I., Sleeper, L.A., Dukes, K.A., Embury, S.H., Bellevue, R., Koshy, M., Moohr, J.W. & Smith, J. (1991) Sickle cell disease as a cause of osteonecrosis of the femoral head. New England Journal of Medicine, 325, 14761481.
  • Milner, P.F., Kraus, A.P., Sebes, J.I., Sleeper, L.A., Dukes, K.A., Embury, S.H., Bellevue, R., Koshy, M., Moohr, J.W. & Smith, J. (1993) Osteonecrosis of the humeral head in sickle cell disease. Clinical Orthopaedics, 289, 136143.
  • Mollapour, E., Porter, J.B., Kaczmarski, R., Linch, D.C. & Roberts, P.J. (1998) Raised neutrophil phospholipase A2 activity and defective priming of NADPH oxidase and phospholipase A2 in sickle cell disease. Blood, 91, 34233429.
  • Month, S.R., Wood, R.W., Trifillis, P.T., Orchowski, P.J., Sharon, B., Ballas, S.K., Surrey, S. & Schwartz, E. (1990) Analysis of 5′ flanking regions of the gamma globin genes from major African haplotype backgrounds associated with sickle cell disease. Journal of Clinical Investigation, 85, 364370.
  • Morris, J., Dunn, D., Beckford, M., Grandison, Y., Mason, K., Higgs, D., DeCeulaer, K., Serjeant, B. & Serjeant, G. (1991) The haematology of homozygous sickle cell disease after the age of 40 years. British Journal of Haematology, 77, 382.
  • Morris, J.S., Dunn, D.T., Poddar, D. & Serjeant, G.R. (1994) Haematological risk factors for pregnancy outcome in Jamaican women with homozygous sickle cell disease. British Journal of Obstetrics and Gynaecology, 101, 770773.
  • Mouele, R., Pambou, O., Feingold, J. & Galacteros, F. (2000) Alpha-thalassemia in Bantu population from Congo-Brazzaville: its interaction with sickle cell anemia. Human Heredity, 50, 118125.
  • Mukherjee, M.B., Surve, R., Tamankar, A., Gangakhedkar, R.R., Ghosh, K., Lu, C.Y., Krishnamoorthy, R., Colah, R. & Mohanty, D. (1998) The influence of alpha-thalassaemia on the haematological & clinical expression of sickle cell disease in western India. Indian Journal of Medical Research, 107, 178181.
  • Nagel, R.L. & Fleming, A. (1992) Epidemiology of the βS gene. Bailliere's Clinical Haematology, 5, 331365.
  • Nagel, R.L. & Labie, D. (1989) DNA haplotypes and the beta s globin gene [Review]. Progress In Clinical and Biological Research, 316B, 371393.
  • Nagel, R.L. & Steinberg, M.H. (2001) Genetics of the βS gene: origins, epidemiology, and epistasis. In: Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management (ed. by M. H.Steinberg, B. G.Forget, D. R.Higgs & R. L.Nagel), pp. 711755. Cambridge University Press, Cambridge.
  • Nagel, R.L., Fabry, M.E., Pagnier, J., Zohoun, I., Wajcman, H., Baudin, V. & Labie, D. (1984) Hematologically and genetically distinct forms of sickle cell anemia in Africa. The Senegal type and the Benin type. New England Journal of Medicine, 312, 880884.
  • Nagel, R.L., Rao, S.K., Dunda-Belkhodja, O., Connolly, M.M., Fabry, M.E., Georges, A., Krishnamoorthy, R. & Labie, D. (1987) The hematologic characteristics of sickle cell anemia bearing the Bantu haplotype: the relationship between G gamma and HbF level. Blood, 69, 10261030.
  • Neonato, M.G., Guilloud-Bataille, M., Beauvais, P., Begue, P., Belloy, M., Benkerrou, M., Ducrocq, R., Maier-Redelsperger, M., De Montalembert, M., Quinet, B., Elion, J., Feingold, J. & Girot, R. (2000) Acute clinical events in 299 homozygous sickle cell patients living in France. French Study Group on Sickle Cell Disease. European Journal of Haematology, 65, 155164.
  • Newburger, P.E., Subrahmanyam, Y.V. & Weissman, S.M. (2000) Global analysis of neutrophil gene expression. Current Opinion in Hematology, 7, 1620.
  • Nichols, W.C., Koller, D.L., Slovis, B., Foroud, T., Terry, V.H., Arnold, N.D., Siemieniak, D.R., Wheeler, L., Phillips, J.A. III., Newman, J.H., Conneally, P.M., Ginsburg, D. & Loyd, J.E. (1997) Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31–32. Nature Genetics, 15, 277280.
  • Nolan, V.G., Baldwin, C.T., Ma, Q.-L., Wyszynski, D.F., Amirault, Y., Farrell, J.J., Bisbee, A., Embury, S.H., Farrer, L.A. & Steinberg, M.H. (2004) Association of single nucleotide polymorphisms in KLOTHO with priapism in sickle cell anemia. British Journal of Haematology, 128, 266272.
  • Odenheimer, D.J., Sarnaik, S.A., Whitten, C.F., Rucknagel, D.L. & Sing, C.F. (1987) The relationship between fetal hemoglobin and disease severity in children with sickle cell anemia. American Journal of Medical Genetics, 27, 525535.
  • Ofori-Acquah, S.F., Lalloz, M.R.A. & Layton, D.M. (1999) Localisation of cis regulatory elements at the β-globin locus: analysis of hybrid haplotype chromosomes. Biochemical and Biophysical Research Communications, 254, 181187.
  • Ofori-Acquah, S.F., Lalloz, M.R., Serjeant, G. & Layton, D.M. (2004) Dominant influence of gamma-globin promoter polymorphisms on fetal haemoglobin expression in sickle cell disease. Cellular and Molecular Biology, 50, 3542.
  • Ohene-Frempong, K. & Nkrumah, F.K. (1994) Sickle cell disease in Africa. In: Sickle Cell Disease: Basic Principles and Clinical Practice (ed. by S. H.Embury, R. P.Hebbel & N.Mohandas), pp. 423435. Raven Press, New York.
  • Ohene-Frempong, K., Weiner, S.J., Sleeper, L.A., Miller, S.T., Embury, S., Moohr, J.W., Wethers, D.L., Pegelow, C.H., Gill, F.M. & Cooperative Study Sickle Cell Disease (1998) Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood, 91, 288294.
  • Öner, C., Dimovski, A.J., Olivieri, N.F., Schiliro, G., Codrington, J.F., Fattoum, S., Adekile, A.D., Öner, R., Yüregir, G.T., Altay, Ç., Gurgey, A., Gupta, R.B., Jogessar, V.B., Kitundu, M.N., Loukopoulos, D., Tamagnini, G.P., Ribeiro, M.L.S., Kutlar, F., Gu, L.-H., Lanclos, K.D. & Huisman, T.H.J. (1992) βs Haplotypes in various world populations. Human Genetics, 89, 99104.
  • Padmos, M.A., Roberts, G.T., Sackey, K., Kulozik, A., Bail, S., Morris, J.S., Serjeant, B.E. & Serjeant, G.R. (1991) Two different forms of homozygous sickle cell disease occur in Saudi Arabia. British Journal of Haematology, 79, 9398.
  • Passon, R.G., Howard, T.A., Zimmerman, S.A., Schultz, W.H. & Ware, R.E. (2001) Influence of bilirubin uridine diphosphate-glucuronosyltransferase 1A promoter polymorphisms on serum bilirubin levels and cholelithiasis in children with sickle cell anemia. Journal of Pediatric Hematology and Oncology, 23, 448451.
  • Pegelow, C.H., Colangelo, L., Steinberg, M., Wright, E.C., Smith, J., Phillips, G. & Vichinsky, E. (1997) Natural history of blood pressure in sickle cell disease: risks for stroke and death associated with relative hypertension in sickle cell anemia. American Journal of Medicine, 102, 171177.
  • Platt, O.S., Thorington, B.D., Brambilla, D.J., Milner, P.F., Rosse, W.F., Vichinsky, E. & Kinney, T.R. (1991) Pain in sickle cell disease-rates and risk factors. New England Journal of Medicine, 325, 1116.
  • Platt, O.S., Brambilla, D.J., Rosse, W.F., Milner, P.F., Castro, O., Steinberg, M.H. & Klug, P.P. (1994) Mortality in sickle cell disease: life expectancy and risk factors for early death. New England Journal of Medicine, 330, 16391644.
  • Plonczynski, M., Figueiredo, M.S. & Steinberg, M.H. (1997) Fetal hemoglobin in sickle cell anemia: examination of phylogenetically conserved sequences within the locus control region but outside the cores of hypersensitive sites 2 and 3. Blood Cells, Molecules, and Diseases, 23, 188200.
  • Powars, D.R. (1991a) Sickle cell anemia: βs-gene-cluster haplotypes as prognostic indicators of vital organ failure. Seminars in Hematology, 28, 202208.
  • Powars, D.R. (1991b) βs-Gene-cluster haplotypes in sickle cell anemia: clinical and hematologic features. Hematology/Oncology Clinics of North America, 5, 475493.
  • Powars, D., Schroeder, W.A., Weiss, J.N., Chan, L.S. & Azen, S.P. (1980) Lack of influence of fetal hemoglobin levels or erythrocyte indices on the severity of sickle cell anemia. Journal of Clinical Investigation, 65, 732740.
  • Powars, D., Weiss, J.N., Chan, L.S. & Schroeder, W.A. (1984) Is there a threshold level of fetal hemoglobin that ameliorates morbidity in sickle cell anemia? Blood, 63, 921926.
  • Powars, D.R., Elliott Mills, D.D. & Chan, L. (1991) Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality. Annals of Internal Medicine, 115, 614620.
  • Powars, D.R., Meiselman, H.J., Fisher, T.C., Hiti, A. & Johnson, C. (1994) Beta-S gene cluster haplotypes modulate hematologic and hemorheologic expression in sickle cell anemia. Use in predicting clinical severity. American Journal of Pediatric Hematology and Oncology, 16, 5561.
  • Powars, D.R., Hiti, A., Ramicone, E., Johnson, C. & Chan, L. (2002) Outcome in hemoglobin SC disease: a four-decade observational study of clinical, hematologic, and genetic factors. American Journal of Hematology, 70, 206215.
  • Ragusa, A., Lombardo, M., Sortino, G., Lombardo, T., Nagel, R.L. & Labie, D. (1988) Beta S gene in Sicily is in linkage disequilibrium with the Benin haplotype: implications for gene flow. American Journal of Hematology, 27, 139141.
  • Reiter, C.D., Wang, X., Tanus-Santos, J.E., Hogg, N., Cannon, R.O. III., Schechter, A.N. & Gladwin, M.T. (2002) Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nature Medicine, 8, 13831389.
  • Romana, M., Muralitharan, S., Ramasawmy, R., Nagel, R.L. & Krishnamoorthy, R. (2002) Thrombosis-associated gene variants in sickle cell anemia. Thrombosis and Haemostasis, 87, 356358.
  • Romana, M., Diara, J.P., Doumbo, L., Muralitharan, S., Ramaswamy, R., Keclard, L., Tarer, V., Chaar, V., Elion, J., Krishnamoorthy, R. & Clayton, J. (2004) Angiotensinogen gene associated polymorphisms and risk of stroke in sickle cell anemia: additional data supporting an association. American Journal of Hematology, 76, 310311.
  • Rucknagel, D.L., Hanash, S.H., Sing, C.F., Winter, W.P., Whitten, C.F. & Prasad, A.S. (1979) Age and sex effects on hemoglobin F in sickle cell anemia. In: Cellular and Molecular Regulation of Hemoglobin Switching (ed. by G.Stamatoyannopoulos & A. W.Nienhuis), pp. 107118. Grune & Stratton, New York.
  • Sabo, P.J., Hawrylycz, M., Wallace, J.C., Humbert, R., Yu, M., Shafer, A., Kawamoto, J., Hall, R., Mack, J., Dorschner, M.O., McArthur, M. & Stamatoyannopoulos, J.A. (2004) Discovery of functional noncoding elements by digital analysis of chromatin structure. Proceedings of the National Academy of Sciences of the United States of America, 101, 1683716842.
  • Saleh, A.W., Hillen, H.F.P. & Duits, A.J. (1999) Levels of endothelial, neutrophil and platelet-specific factors in sickle cell anemia patients during hydroxyurea therapy. Acta Haematologica, 102, 3137.
  • Sarnaik, S.A. & Ballas, S.K. (2001) Molecular characteristics of pediatric patients with sickle cell anemia and stroke. American Journal of Hematology, 67, 179182.
  • Schroeder, W.A., Powars, D.R., Kay, L.M., Chan, L.S., Huynh, V., Shelton, J.B. & Shelton, J.R. (1989) β-Cluster haplotypes α-gene status and hematological data from SS SC and S-β-thalassemia patients in southern California. Hemoglobin, 13, 325353.
  • Sebastiani, P., Nolan, V.G., Baldwin, C.T. & Steinberg, M.H. (2004) Modeling Phenotype Interactions in Sickle Cell Anemia. Blood, 104, 461a.
  • Sebastiani, P., Ramoni, M.F., Nolan, V.G., Baldwin, C.T. & Steinberg, M.H. (2005) Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia. Nature Genetics (in press).
  • Serjeant, G.R., Singhal, A. & Hambleton, I.R. (2001) Sickle cell disease and age at menarche in Jamaican girls: observations from a cohort study. Archives of Diseases in Childhood, 85, 375378.
  • Setty, B.N., Stuart, M.J., Dampier, C., Brodecki, D. & Allen, J.L. (2003) Hypoxaemia in sickle cell disease: biomarker modulation and relevance to pathophysiology. Lancet, 362, 14501455.
  • Sharan, K., Surrey, S., Ballas, S., Borowski, M., Devoto, M., Wang, K.F., Sandler, E. & Keller, M. (2004) Association of T-786C eNOS gene polymorphism with increased susceptibility to acute chest syndrome in females with sickle cell disease. British Journal of Haematology, 124, 240243.
  • Sharon, B., Poncz, M., Surrey, S. & Schwartz, E. (1988) Non-random association of the Rsa I polymorphic site 5′ to the beta-globin gene with major sickle cell haplotypes. Hemoglobin, 12, 115124.
  • Singhal, A., Morris, J., Thomas, P., Dover, G., Higgs, D. & Serjeant, G. (1996) Factors affecting prepubertal growth in homozygous sickle cell disease. Archives of Disease in Childhood, 74, 502506.
  • Srinivas, R., Dunda, O., Krishnamoorthy, R., Fabry, M.E., Georges, A., Labie, D. & Nagel, R.L. (1988) Atypical haplotypes linked to the beta S gene in Africa are likely to be the product of recombination. American Journal of Hematology, 29, 6062.
  • Steinberg, M.H. & Embury, S.H. (1986) Alpha-thalassemia in blacks: genetic and clinical aspects and interactions with the sickle hemoglobin gene [Review]. Blood, 68, 985990.
  • Steinberg, M.H., Dreiling, B.J., Morrison, F.S. & Necheles, T.F. (1973) Mild sickle cell disease. Clinical and laboratory studies. JAMA, 224, 317321.
  • Steinberg, M.H., Rosenstock, W., Coleman, M.B., Adams, J.G. III., Platica, O., Cedeno, M., Rieder, R.F., Wilson, J.T., Milner, P. & West, S. (1984) Effects of thalassemia and microcytosis upon the hematological and vaso-occlusive severity of sickle cell anemia. Blood, 63, 13531360.
  • Steinberg, M.H., Hsu, H., Nagel, R.L., Milner, P.F., Adams, J.G., Benjamin, L., Fryd, S., Gillette, P., Gilman, J., Josifovska, O., Hellman-Erlingsson, S., Safaya, S., Huey, L. & Rieder, R.F. (1995a) Gender and haplotype effects upon hematological manifestations of adult sickle cell anemia. American Journal of Hematology, 48, 175181.
  • Steinberg, M.H., Ballas, S.K., Brunson, C.Y. & Bookchin, R. (1995b) Sickle cell anemia in septuagenarians. Blood, 86, 39973998.
  • Steinberg, M.H., Lu, Z.-H., Barton, F.B., Terrin, M.L., Charache, S., Dover, G.J. & Multicenter Study of Hydroxyurea (1997) Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Blood, 89, 10781088.
  • Steinberg, M.H., Barton, F., Castro, O., Pegelow, C.H., Ballas, S.K., Kutlar, A., Orringer, E., Bellevue, R., Olivieri, N., Eckman, J., Varma, M., Ramirez, G., Adler, B., Smith, W., Carlos, T., Ataga, K., DeCastro, L., Bigelow, C., Saunthararajah, Y., Telfer, M., Vichinsky, E., Claster, S., Shurin, S., Bridges, K., Waclawiw, M., Bonds, D. & Terrin, M. (2003a) Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA, 289, 16451651.
  • Steinberg, M.H., Voskaridou, E., Kutlar, A., Loukopoulos, D., Koshy, M., Ballas, S.K., Castro, O. & Barton, F. (2003b) Concordant fetal hemoglobin response to hydroxyurea in siblings with sickle cell disease. American Journal of Hematology, 72, 121126.
  • Steinberg, M.H., Baldwin, C.T., Wyszynski, D.F., Nolan, V.G., Amirault, Y., Farrell, J.J., Bisbee, A., Gavras, H., Farrer, L.A., Adams, R., Gallagher, D.M., Iyer, R. & Bigelow, C. (2003c) Stroke in sickle cell anemia: association with single nucleotide polymorphisms in genes affecting vascular function. Blood, 102, 406a.
  • Steinberg, M.H., Nolan, V.G., Baldwin, C.T., Wyszynski, D.F., Amirault, Y., Bisbee, A., Gavras, H., Farrell, J.J., Gallagher, D., Iyer, R.V. & Bigelow, C. (2003d) Association of polymorphisms in genes of the transforming growth factor-β pathway with sickle cell osteonecrosis. Blood, 102, 926a.
  • Styles, L.A., Schalkwijk, C.G., Aarsman, A.J., Vichinsky, E.P., Lubin, B.H. & Kuypers, F.A. (1996) Phospholipase A2 levels in acute chest syndrome of sickle cell disease. Blood, 87, 25732578.
  • Styles, L.A., Hoppe, C., Klitz, W., Vichinsky, E., Lubin, B. & Trachtenberg, E. (2000a) Evidence for HLA-related susceptibility for stroke in children with sickle cell disease. Blood, 95, 35623567.
  • Styles, L.A., Aarsman, A.J., Vichinsky, E.P. & Kuypers, F.A. (2000b) Secretory phospholipase A2 predicts impending acute chest syndrome in sickle cell disease. Blood, 96, 32763278.
  • Sullivan, K.J., Kissoon, N., Duckworth, L.J., Sandler, E., Freeman, B., Bayne, E., Sylvester, J.E. & Lima, J.J. (2001) Low exhaled nitric oxide and a polymorphism in the NOS I gene is associated with acute chest syndrome. American Journal of Respiratory and Critical Care Medicine, 164, 21862190.
  • Tang, D.C., Prauner, R., Liu, W., Kim, K.H., Hirsch, R.P., Driscoll, M.C. & Rodgers, G.P. (2001) Polymorphisms within the angiotensinogen gene (GT-repeat) and the risk of stroke in pediatric patients with sickle cell disease: a case-control study. American Journal of Hematology, 68, 164169.
  • Tanimoto, K. & Engel, J.D. (2000) In vivo modulation of human β-globin gene switching. Trends in Cardiovascular Medicine, 10, 1519.
  • Tankut, G., Kutlar, F., McKie, V., McKie, K., Holley, L., Adekile, A., Clair, B., Kilinc, Y. & Kutlar, A. (2000) Frequency of the factor V R485K polymorphism in sickle cell disease: a potential genetic modifier. Blood, 96, 13a.
  • Taylor, J.G., Tang, D.C., Savage, S.A., Leitman, S.F., Heller, S.I., Serjeant, G.R., Rodgers, G.P. & Chanock, S.J. (2002a) Variants in the VCAM1 gene and risk for symptomatic stroke in sickle cell disease. Blood, 100, 43034309.
  • Taylor, J.G., Tang, D., Foster, C.B., Serjeant, G.R., Rodgers, G.P. & Chanock, S.J. (2002b) Patterns of low-affinity immunoglobulin receptor polymorphisms in stroke and homozygous sickle cell disease. American Journal of Hematology, 69, 109114.
  • Thein, S.L., Sampietro, M., Rohde, K., Rochette, J., Weatherall, D.J., Lathrop, G.M. & Demenais, F. (1994) Detection of a major gene for heterocellular hereditary persistence of fetal hemoglobin after accounting for genetic modifiers. American Journal of Human Genetics, 54, 214228.
  • Thomas, P.W., Higgs, D.R. & Serjeant, G.R. (1997) Benign clinical course in homozygous sickle cell disease: a search for predictors. Journal of Clinical Epidemiology, 50, 121126.
  • Tuan, D., Solomon, W., Li, Q. & London, I.M. (1985) The “β-like-globin” gene domain in human erythroid cells. Proceedings of the National Academy of Sciences of the United States of America, 82, 63846388.
  • Valafar, H., Valafar, F., Darvill, A., Albersheim, P., Kutlar, A., Woods, K.F. & Hardin, J. (2000) Predicting the effectiveness of hydroxyurea in individual sickle cell anemia patients. Artifical Intellegence and Medicine, 18, 133148.
  • Wali, Y.A., Al Lamki, Z., Hussein, S.S., Bererhi, H., Kumar, D., Wasifuddin, S., Zachariah, M. & Ghosh, K. (2002) Splenic function in Omani children with sickle cell disease: correlation with severity index, hemoglobin phenotype, iron status, and alpha-thalassemia trait. Pediatric Hematology and Oncology, 19, 491500.
  • Ware, R.E., Eggleston, B., Redding-Lallinger, R., Wang, W.C., Smith-Whitley, K., Daeschner, C., Gee, B., Styles, L.A., Helms, R.W., Kinney, T.R. & Ohene-Frempong, K. (2002) Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy. Blood, 99, 1014.
  • Weiss, M.J. & Orkin, S.H. (1995) GATA transcription factors: key regulators of hematopoiesis. Experimental Hematology, 23, 99107.
  • West, M.S., Wethers, D., Smith, J., Steinberg, M.H. & Coop Study of Sickle Cell Disease (1992) Laboratory profile of sickle cell disease: a cross-sectional analysis. Journal of Clinical Epidemiology, 45, 893909.
  • Wick, G., Schett, G., Amberger, A., Kleindienst, R. & Xu, Q. (1995) Is atherosclerosis an immunologically mediated disease? Immunology Today, 16, 2733.
  • Wyszynski, D.F., Baldwin, C.T., Cleves, M.A., Amirault, Y., Nolan, V.G., Farrell, J.J., Bisbee, A., Kutlar, A., Farrer, L.A. & Steinberg, M.H. (2004a) Polymorphisms near a chromosome 6q QTL area are associated with modulation of fetal hemoglobin levels in sickle cell anemia. Cellular and Molecular Biology, 50, 2333.
  • Wyszynski, D.F., Baldwin, C.T., Cleves, M.A., Farrell, J.J., Bisbee, A., Kutlar, A., Farrer, L.A. & Steinberg, M.H. (2004b) Genetic polymorphisms associated with fetal hemoglobin response to hyroxyurea in patients with sickle cell anemia. Blood, 104, 34a.
  • Yang, Y.M., Pace, B., Kitchens, D., Ballas, S.K., Shah, A. & Baliga, B.S. (1997) BFU-E colony growth in response to hydroxyurea: correlation between in vitro and in vivo fetal hemoglobin induction. American Journal of Hematology, 56, 252258.
  • Zago, M.A., Figueiredo, M.S. & Ogo, S.H. (1992) Bantu βs cluster haplotype predominates among Brazilian Blacks. American Journal of Physical Anthropology, 88, 295298.
  • Zennadi, R., Hines, P.C., De Castro, L.M., Cartron, J.P., Parise, L.V. & Telen, M.J. (2004) Epinephrine acts through erythroid signaling pathways to activate sickle cell adhesion to endothelium via LW-alpha v beta 3 interactions. Blood, 104, 37743781.
  • Zimmerman, S.A. & Ware, R.E. (1998) Inherited DNA mutations contributing to thrombotic complications in patients with sickle cell disease. American Journal of Hematology, 59, 267272.
  • Zimmerman, S.A., Howard, T.A., Whorton, M.R., Rosse, W.F. & Ware, R.E. (1998) The A312G polymorphism in α-fibrinogen is associated with stroke and avascular necrosis in patients with sickle cell anemia. Blood, 92, 36b.
  • Zimmerman, S.A., Schultz, W.H., Davis, J.S., Pickens, C.V., Mortier, N.A., Howard, T.A. & Ware, R.E. (2004) Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease. Blood, 103, 20392045.
  • Zou, L.P., Guo, Y.H., Fang, F., Jin, H., Wu, H.S. & Mix, E. (2002) Evidence for human leukocyte antigen-related susceptibility in idiopathic childhood ischemic stroke. European Neurology, 48, 153157.